Skip to main content
Premium Trial:

Request an Annual Quote

Genome Canada Earmarks $48M for Applied Genomics and Proteomics

NEW YORK June 23 - Genome Canada said today that it would make up to Can$65 million (US$48 million) available for a competitive grant program focused on applied genomics and proteomics research.


The Applied Genomics and Proteomics Research in Human Health Competition will support the development of genomics and proteomics tools to improve the prediction, prevention, and treatment of human disease. According to Genome Canada, the initiative is seeking research projects "that will lead to practical applications in hospitals, community clinics, and the population at large" within five years.


Guidelines, application forms, and evaluation criteria for the program are available here.


Researchers have until July 3 to submit their intention to participate, and final proposals will be made in the fall. Genome Canada said a decision on which projects will be funded should be made by April 2004.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.